The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10180 malaria professionals are enjoying the free benefits of MalariaWorld today

adjunctive therapy

Open Access | Study Protocol: Inhaled Nitric Oxide for the Adjunctive Therapy of Severe Malaria: Protocol for a Randomized Controlled Trial

July 20, 2011 - 15:00 -- Patrick Sampao
Author(s): 
Michael Hawkes, Robert O Opoka, Kevin C Kain, et al.
Reference: 
Trials 2011, 12:176

This prospective, parallel arm, randomized, placebo-controlled, blinded clinical trial compares adjunctive continuous inhaled nitric oxide at 80 ppm to placebo (both arms receiving standard anti-malarial therapy), among Ugandan children aged 1-10 years of age with severe malaria.

Product: 
Medical Condition: 
Medical Treatment: 
Subscribe to RSS - adjunctive therapy